Fumio Nambu

401 total citations
20 papers, 352 citations indexed

About

Fumio Nambu is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Fumio Nambu has authored 20 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Pharmacology. Recurrent topics in Fumio Nambu's work include Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Fumio Nambu is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (6 papers) and Inflammatory mediators and NSAID effects (6 papers). Fumio Nambu collaborates with scholars based in Japan, China and United States. Fumio Nambu's co-authors include Yutaka Okada, Takaaki Obata, Naoki Nakagawa, Yoshihiro Urade, Shu Narumiya, Naomi Eguchi, Weimin Qu, Zhi‐Li Huang, Kosuke Aritake and Osamu Hayaishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Allergy and Clinical Immunology and European Journal of Pharmacology.

In The Last Decade

Fumio Nambu

20 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Nambu Japan 9 157 99 79 78 60 20 352
Hideo Umeuchi Japan 8 129 0.8× 108 1.1× 7 0.1× 17 0.2× 12 0.2× 11 419
J Talesnik Canada 11 93 0.6× 119 1.2× 9 0.1× 72 0.9× 13 0.2× 28 471
Sohyeon Moon South Korea 11 58 0.4× 131 1.3× 11 0.1× 20 0.3× 25 0.4× 24 366
Mariana Lemos Duarte United States 12 76 0.5× 177 1.8× 14 0.2× 27 0.3× 9 0.1× 18 374
Kaoru Nakao Japan 14 117 0.7× 286 2.9× 7 0.1× 25 0.3× 27 0.5× 37 613
Shuhei Horio Japan 11 103 0.7× 161 1.6× 11 0.1× 12 0.2× 10 0.2× 28 334
Paul R. Nemeth United States 15 109 0.7× 208 2.1× 55 0.7× 20 0.3× 9 0.1× 23 599
Chika Miyoshi Japan 12 65 0.4× 268 2.7× 12 0.2× 15 0.2× 140 2.3× 24 513
Jiping Su China 11 85 0.5× 131 1.3× 28 0.4× 15 0.2× 34 0.6× 29 398
Tim Sonntag United States 6 143 0.9× 149 1.5× 7 0.1× 10 0.1× 28 0.5× 8 491

Countries citing papers authored by Fumio Nambu

Since Specialization
Citations

This map shows the geographic impact of Fumio Nambu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Nambu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Nambu more than expected).

Fields of papers citing papers by Fumio Nambu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Nambu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Nambu. The network helps show where Fumio Nambu may publish in the future.

Co-authorship network of co-authors of Fumio Nambu

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Nambu. A scholar is included among the top collaborators of Fumio Nambu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Nambu. Fumio Nambu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okada, Yutaka, et al.. (2016). Effect of ONO-4053 on Fc Epsilon RI Stimulated-Mast Cell Activation. Journal of Allergy and Clinical Immunology. 137(2). AB77–AB77. 1 indexed citations
2.
Kitamine, Tetsuya, Atsuto Inoue, Takafumi Nakao, et al.. (2015). Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma. European Journal of Pharmacology. 765. 242–248. 11 indexed citations
3.
Okada, Yutaka, et al.. (2015). Effect of ONO-4053, a DP1 (prostaglandin D2 receptor) Antagonist, on Prostaglandin D2-Induced Nasal Congestion. Journal of Allergy and Clinical Immunology. 135(2). AB219–AB219. 1 indexed citations
4.
Takahashi, Eiji, Motoyuki Tanaka, Yutaka Okada, et al.. (2011). Design and synthesis of new prostaglandin D2 receptor antagonists. Bioorganic & Medicinal Chemistry. 19(18). 5361–5371. 2 indexed citations
5.
Okada, Yutaka, et al.. (2011). Discovery of selective indole-based prostaglandin D2 receptor antagonist. Bioorganic & Medicinal Chemistry. 19(15). 4574–4588. 11 indexed citations
6.
Naganawa, Atsushi, Atsushi Kinoshita, Seiji Ogawa, et al.. (2011). Discovery of new orally active prostaglandin D2 receptor antagonists. Bioorganic & Medicinal Chemistry. 19(22). 6935–6948. 3 indexed citations
7.
Qu, Weimin, Zhi‐Li Huang, Kosuke Aritake, et al.. (2006). Lipocalin-type prostaglandin D synthase produces prostaglandin D 2 involved in regulation of physiological sleep. Proceedings of the National Academy of Sciences. 103(47). 17949–17954. 125 indexed citations
8.
Nambu, Fumio, et al.. (1997). Effects of Steroid 5.ALPHA.-Reductase Inhibitor ONO-9302 and Anti-Androgen Allylestrenol on the Prostatic Growth, and Plasma and Prostatic Hormone Levels in Rats.. The Japanese Journal of Pharmacology. 74(3). 243–252. 8 indexed citations
9.
Miyazaki, Makoto, et al.. (1997). Synthesis of a Novel Class of Water-Soluble and Bioavailable Antioxidants: 5-Hydroxycoumaran Derivatives Possessing Imidazole Group. Synlett. 1997(Sup. I). 511–512. 2 indexed citations
10.
Nambu, Fumio, et al.. (1997). Effects of Steroid 5α-Reductase Inhibitor ONO-9302 and Anti-Androgen Allylestrenol on the Prostatic Growth, and Plasma and Prostatic Hormone Levels in Rats. The Japanese Journal of Pharmacology. 74(3). 243–252. 1 indexed citations
11.
Nakagawa, Naoki, et al.. (1993). Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. European Journal of Pharmacology. 235(2-3). 211–219. 44 indexed citations
12.
Nakagawa, Takemasa, Naomi Yamashita, Yutaka Mizushima, et al.. (1992). Inhibition of Allergic Bronchoconstriction in Guinea Pigs and in Asthmatics by the Leukotriene Antagonist ONO-1078. International Archives of Allergy and Immunology. 99(2-4). 490–492. 2 indexed citations
13.
Nakagawa, Naoki, et al.. (1992). In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist.. The Japanese Journal of Pharmacology. 60(3). 217–225. 81 indexed citations
14.
Nakagawa, Naoki, et al.. (1992). In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist. The Japanese Journal of Pharmacology. 60(3). 217–225. 20 indexed citations
15.
Nambu, Fumio, et al.. (1991). Inhibition of endothelin-induced bronchoconstriction by OKY-046, a selective thromboxane A2 synthetase inhibitor, in guinea pigs.. PubMed. 21A. 453–6. 9 indexed citations
16.
Ishii, Akira, et al.. (1990). Inhibition of Endogenous Leukotriene-Mediated Lung Anaphylaxis in Guinea Pigs by a Novel Receptor Antagonist ONO-1078. International Archives of Allergy and Immunology. 92(4). 404–407. 10 indexed citations
17.
Nambu, Fumio, et al.. (1990). Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs.. The Japanese Journal of Pharmacology. 52(2). 307–317. 7 indexed citations
18.
19.
Nambu, Fumio, et al.. (1990). Inhibitory Effects of OKY-046 on Spasmogen-lnduced Bronchoconstrictions in Sensitized and Non-Sensitized Guinea Pigs. The Japanese Journal of Pharmacology. 52(2). 307–318. 1 indexed citations
20.
Nambu, Fumio, et al.. (1989). Effect of an oral thromboxane synthetase inhibitor (OKY-046) on antigen-induced bronchoconstriction in guinea pigs.. PubMed. 19. 528–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Umeuchi Breakdown of academic impact, for papers by J Talesnik Breakdown of academic impact, for papers by Sohyeon Moon Breakdown of academic impact, for papers by Mariana Lemos Duarte Breakdown of academic impact, for papers by Kaoru Nakao Breakdown of academic impact, for papers by Shuhei Horio Breakdown of academic impact, for papers by Paul R. Nemeth Breakdown of academic impact, for papers by Chika Miyoshi Breakdown of academic impact, for papers by Jiping Su Breakdown of academic impact, for papers by Tim Sonntag
Rankless by CCL
2026